Your browser doesn't support javascript.
loading
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.
Boise, L H; Minn, A J; Noel, P J; June, C H; Accavitti, M A; Lindsten, T; Thompson, C B.
Afiliación
  • Boise LH; Gwen Knapp Center for Lupus and Immunology Research, Department of Medicine, University of Chicago, Illinois 60637, USA.
Immunity ; 3(1): 87-98, 1995 Jul.
Article en En | MEDLINE | ID: mdl-7621080
ABSTRACT
T cell activation through the TCR can result in either cell proliferation or cell death. The role of costimulatory receptors in regulating T cell survival has not been defined. Here, we present data demonstrating that CD28 costimulation enhances the in vitro survival of activated T cells. One mechanism for this enhancement is the ability of CD28 costimulation to augment the production of IL-2, which acts as an extrinsic survival factor for T cells. In addition, CD28 costimulation augments the intrinsic ability of T cells to resist apoptosis. Although CD28 signal transduction had no effect on Bcl-2 expression, CD28 costimulation was found to augment the expression of Bcl-XL substantially. Transfection experiments demonstrated that this level of Bcl-XL could prevent T cell death in response to TCR cross-linking, Fas cross-linking, or IL-2 withdrawal. These data suggest that an important role of CD28 costimulation is to augment T cell survival during antigen activation.
Asunto(s)
Buscar en Google
Colección: 01-internacional Asunto principal: Linfocitos T / Proteínas Proto-Oncogénicas / Antígenos CD28 Límite: Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Asunto principal: Linfocitos T / Proteínas Proto-Oncogénicas / Antígenos CD28 Límite: Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos